SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines.

Gillon, TE; Pels, A; von Dadelszen, P; MacDonell, K; Magee, LA (2014) Hypertensive disorders of pregnancy: a systematic review of international clinical practice guidelines. PLoS One, 9 (12). ISSN 1932-6203 https://doi.org/10.1371/journal.pone.0113715
SGUL Authors: von Dadelszen, Peter

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (368kB) | Preview

Abstract

BACKGROUND: Clinical practice guidelines (CPGs) are developed to assist health care providers in decision-making. We systematically reviewed existing CPGs on the HDPs (hypertensive disorders of pregnancy) to inform clinical practice. METHODOLOGY & PRINCIPAL FINDINGS: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Methodology Register, Health Technology Assessments, and Database of Abstracts of Reviews of Effects (Ovid interface), Grey Matters, Google Scholar, and personal records were searched for CPGs on the HDPs (Jan/03 to Nov/13) in English, French, Dutch, or German. Of 13 CPGs identified, three were multinational and three developed for community/midwifery use. Length varied from 3-1188 pages and three guidelines did not formulate recommendations. Eight different grading systems were identified for assessing evidence quality and recommendation strength. No guideline scored ≧80% on every domain of the AGREE II, a tool for assessing guideline methodological quality; two CPGs did so for 5/6 domains. Consistency was seen for (i) definitions of hypertension, proteinuria, chronic and gestational hypertension; (ii) pre-eclampsia prevention for women at increased risk: calcium when intake is low and low-dose aspirin, but not vitamins C and E or diuretics; (iii) antihypertensive treatment of severe hypertension; (iv) MgSO4 for eclampsia and severe pre-eclampsia; (v) antenatal corticosteroids at <34 wks when delivery is probable within 7 days; (vi) delivery for women with severe pre-eclampsia pre-viability or pre-eclampsia at term; and (vii) active management of the third stage of labour with oxytocin. Notable inconsistencies were in: (i) definitions of pre-eclampsia and severe pre-eclampsia; (ii) target BP for non-severe hypertension; (iii) timing of delivery for women with pre-eclampsia and severe pre-eclampsia; (iv) MgSO4 for non-severe pre-eclampsia, and (v) postpartum maternal monitoring. CONCLUSIONS: Existing international HDP CPGs have areas of consistency with which clinicians and researchers can work to develop auditable standards, and areas of inconsistency that should be addressed by future research.

Item Type: Article
Additional Information: Copyright: © 2014 Gillon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Databases, Bibliographic, Female, Humans, Hypertension, Pregnancy-Induced, Practice Guidelines as Topic, Pregnancy, General Science & Technology, MD Multidisciplinary
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: PLoS One
Article Number: e113715
ISSN: 1932-6203
Language: eng
Dates:
DateEvent
1 December 2014Published
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 25436639
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/107504
Publisher's version: https://doi.org/10.1371/journal.pone.0113715

Actions (login required)

Edit Item Edit Item